Anita Afzali , MD

Bachelor's Degree: Washington State University Seattle, WA, 2001 (Genetics and Cell Biology)

Medical Degree: University of Washington Seattle, WA, 2006

Internship: University of Washington Seattle, WA, 2008

Fellowship: University of Washington Seattle, WA, 2012 (Gastroenterology)

American Board of Internal Medicine (Gastroenterology) (Certification Date: 11-20-2013 ) - (Recertification Date: to 07-12-2019 )

Gastroenterology

Digestive Diseases

Internal Medicine

Grant: #TAK VDZ-4066 02-27-2025 -02-26-2028 PPD A Real-World Retrospective Study Assessing Medical Charts to evaluate Vedolizumab and Ustekinumab Outcomes for Biologic-naive and Biologic-experienced Crohn's Disease Patients in Canada and the United Role:PI 193692.25 Hold Level:Industry

Grant: #TAK VDZ-4066 02-27-2025 -02-26-2028 PPD A Real-World Retrospective Study Assessing Medical Charts to evaluate Vedolizumab and Ustekinumab Outcomes for Biologic-naive and Biologic-experienced Crohn's Disease Patients in Canada and the United Role:PI 193692.25 Hold Level:Industry

Peer Reviewed Publications

Herfarth, Hans H; Afzali, Anita; Fischer, Monika; Hudesman, David; Abdalla, Maisa; McCabe, Robert; Cohen, Benjamin L; Ungaro, Ryan C; Harlan, Will; Hanson, John; Konijeti, Gauree G; Polyak, Steven; Ritter, Timothy; Salzberg, Bruce; Seminerio, Jennifer; English, Emily; Zhang, Xian; Long, Millie D (2023. ) Clinical long-term outcomes of patient-reported outcomes in the prospective real-world Tofacitinib Response in Ulcerative Colitis (TOUR) registry: Tofacitinib Response in Ulcerative Colitis (TOUR).Clinical and translational gastroenterology, , More Information

Danese, Silvio; Panaccione, Remo; Feagan, Brian G; Afzali, Anita; Rubin, David T; Sands, Bruce E; Reinisch, Walter; Panés, Julián; Sahoo, Aparna; Terry, Natalie A; Chan, Daphne; Han, Chenglong; Frustaci, Mary Ellen; Yang, Zijiang; Sandborn, William J; Hisamatsu, Tadakazu; Andrews, Jane M; D'Haens, Geert R (2023. ) Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial.The lancet. Gastroenterology & hepatology, , More Information

Afzali, Anita; Lukanova, Rina; Hennessy, Fritha; Kakehi, Sumie; Knight, Hannah; Milligan, Gary; Gupte-Singh, Komal (2023. ) Unmet Needs in Real-World Advanced Therapy-Naïve and -Experienced Patients with Moderately to Severely Active Ulcerative Colitis in the United States.Advances in therapy, , 40 (10 ) ,4321-4338 More Information

Danese, Silvio; Panaccione, Remo; Abreu, Maria T; Rubin, David T; Ghosh, Subrata; Dignass, Axel; Afzali, Anita; Wolf, Douglas C; Chiorean, Michael V; Vermeire, Severine; Jain, Anjali; Charles, Lorna; Lawlor, Garrett; Osterman, Mark T; Wu, Hsiuanlin; Canavan, James B; Petersen, Ann Katrin; Colombel, Jean-Frederic; Regueiro, Miguel (2023. ) Efficacy and safety of approximately 3 years of continuous ozanimod in moderately to severely active ulcerative colitis: interim analysis of the True North open-label extension.Journal of Crohn's & colitis, , More Information

Clement, Benjamin; De Felice, Kara; Afzali, Anita (2023. ) Indications and safety of newer IBD treatments in the older patient.Current gastroenterology reports, , 25 (7 ) ,160-168 More Information

Axelrad, Jordan; Long, Millie; Horst, Sara; Afzali, Anita; Sapir, Tamar; Fajardo, Kristina; De Felice, Kara; Sandler, Robert; Cross, Raymond (2022. ) A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled Trial.JMIR research protocols, , 11 (12 ) ,e40382 More Information

Feagan, Brian G; Schreiber, Stefan; Afzali, Anita; Rieder, Florian; Hyams, Jeffrey; Kollengode, Kanthi; Pearlman, Jared; Son, Vladimir; Marta, Cecilia; Wolf, Douglas C; D'Haens, Geert G (2022. ) Ozanimod as a novel oral small molecule therapy for the treatment of Crohn's disease: The YELLOWSTONE clinical trial program.Contemporary clinical trials, , 122 ,106958 More Information

Neyazi, Narges; Safi, Najibullah; Afzali, Anita; Kabir, Misha (2022. ) Gender barriers are worsening women's access to health care in Afghanistan.Lancet (London, England), , 400 (10354 ) ,731-732 More Information

Long, Millie D; Afzali, Anita; Fischer, Monika; Hudesman, David; Abdalla, Maisa; McCabe, Robert; Cohen, Benjamin L; Ungaro, Ryan C; Harlan, Will; Hanson, John; Konijeti, Gauree; Polyak, Steven; Ritter, Timothy; Salzberg, Bruce; Seminerio, Jennifer; English, Emily; Zhang, Xian; Sharma, Puza P; Herfarth, Hans H (2023. ) Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting.Inflammatory bowel diseases, , 29 (4 ) ,570-578 More Information

Johnson, Amanda M; Barsky, Maria; Ahmed, Waseem; Zullow, Samantha; Galati, Jonathan; Jairath, Vipul; Narula, Neeraj; Peerani, Farhad; Click, Benjamin H; Coburn, Elliot S; Dang, ThucNhi Tran; Gold, Stephanie; Agrawal, Manasi; Garg, Rajat; Aggarwal, Manik; Mohammad, Danah; Halloran, Brendan; Kochhar, Gursimran S; Todorowski, Hannah; Ud Din, Nabeeha Mohy; Izanec, James; Teeple, Amanda; Gasink, Chris; Muser, Erik; Ding, Zhijie; Swaminath, Arun; Lakhani, Komal; Hogan, Dan; Datta, Samit; Ungaro, Ryan C; Boland, Brigid S; Bohm, Matthew; Fischer, Monika; Sagi, Sashidhar; Afzali, Anita; Ullman, Thomas; Lawlor, Garrett; Baumgart, Daniel C; Chang, Shannon; Hudesman, David; Lukin, Dana; Scherl, Ellen J; Colombel, Jean-Frederic; Sands, Bruce E; Siegel, Corey A; Regueiro, Miguel; Sandborn, William J; Bruining, David; Kane, Sunanda; Loftus, Edward V; Dulai, Parambir S (2023. ) The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium.The American journal of gastroenterology, , 118 (2 ) ,317-328 More Information

Allen, Kenneth D; Kiefer, Miranda K; Butnariu, Madalina; Afzali, Anita (2022. ) Pregnant women with immune mediated inflammatory diseases who discontinue biologics have higher rates of disease flare.Archives of gynecology and obstetrics, , 306 (6 ) ,1929-1937 More Information

Dulai, Parambir S; Rai, Victoria; Raffals, Laura E; Lukin, Dana; Hudesman, David; Kochhar, Gursimran S; Damas, Oriana M; Sauk, Jenny S; Levy, Alexander N; Sofia, M Anthony; Tuskey, Anne; Deepak, Parakkal; Yarur, Andres J; Afzali, Anita; Ananthakrishnan, Ashwin N; Cross, Raymond K; Hanauer, Stephen B; Siegel, Corey A (2022. ) Recommendations on the Appropriate Management of Steroids and Discharge Planning During and After Hospital Admission for Moderate-Severe Ulcerative Colitis: Results of a RAND Appropriateness Panel.The American journal of gastroenterology, , 117 (8 ) ,1288-1295 More Information

Sandborn, William J; D'Haens, Geert R; Reinisch, Walter; Panés, Julián; Chan, Daphne; Gonzalez, Susana; Weisel, Kathleen; Germinaro, Matthew; Frustaci, Mary Ellen; Yang, Zijiang; Adedokun, Omoniyi J; Han, Chenglong; Panaccione, Remo; Hisamatsu, Tadakazu; Danese, Silvio; Rubin, David T; Sands, Bruce E; Afzali, Anita; Andrews, Jane M; Feagan, Brian G (2022. ) Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study.Gastroenterology, , 162 (6 ) ,1650-1664.e8 More Information

Pusateri, Antoinette; Anaizi, Ahmad; Nemer, Laura; Hinton, Alice; Lara, Luis; Afzali, Anita (2022. ) Impact of Cannabis Use on Inpatient Inflammatory Bowel Disease Outcomes in 2 States Legalizing Recreational Cannabis.Crohn's & colitis 360, , 4 (2 ) ,otac015 More Information

Rubin, David T; Sninsky, Charles; Siegmund, Britta; Sans, Miquel; Hart, Ailsa; Bressler, Brian; Bouhnik, Yoram; Armuzzi, Alessandro; Afzali, Anita (2021. ) International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey.Inflammatory bowel diseases, , 27 (12 ) ,1942-1953 More Information

Pusateri, Antoinette; Hatcher, Ashley; Patel, Nisha; Lehman, Joy; Hinton, Alice; Afzali, Anita (2021. ) Impact of rapid infliximab infusions on access at a large academic tertiary medical center.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, , 78 (22 ) ,2046-2052 More Information

Syal, Gaurav; Serrano, Mariastella; Jain, Animesh; Cohen, Benjamin L; Rieder, Florian; Stone, Christian; Abraham, Bincy; Hudesman, David; Malter, Lisa; McCabe, Robert; Holubar, Stefan; Afzali, Anita; Cheifetz, Adam S; Gaidos, Jill K J; Moss, Alan C (2021. ) Health Maintenance Consensus for Adults With Inflammatory Bowel Disease.Inflammatory bowel diseases, , 27 (10 ) ,1552-1563 More Information

Hemperly, Amy; Dubinsky, Marla C; Yarur, Andres; Afzali, Anita; Hanauer, Stephen; Kugathasan, Subra; Long, Millie D; Rabizadeh, Shervin; Sockolow, Robbyn; Okada, Lauren; Jain, Anjali; Abreu, Maria T; Vande Casteele, Niels (2021. ) Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic Drug Monitoring.Crohn's & colitis 360, , 3 (3 ) ,otab035 More Information

Balzora, Sophie; Afzali, Anita; Bewtra, Meenakshi (2021. ) Social Media-The Next Glass Ceiling?.Gastroenterology, , 161 (1 ) ,373-374 More Information

Afzali, Anita; Furtner, Daniel; Melsheimer, Richard; Molloy, Philip J (2021. ) The Automatic Substitution of Biosimilars: Definitions of Interchangeability are not Interchangeable.Advances in therapy, , 38 (5 ) ,2077-2093 More Information

Pearlstein, Haley; Bricker, Josh; Michel, Hilary K; Afzali, Anita; Donegan, Amy M; Maltz, Ross M; Boyle, Brendan M; Dotson, Jennifer L (2021. ) Predicting Suboptimal Transitions in Adolescents With Inflammatory Bowel Disease.Journal of pediatric gastroenterology and nutrition, , 72 (4 ) ,563-568 More Information

Clark-Snustad, Kindra; Butnariu, Madalina; Afzali, Anita (2020. ) Women's Health and Ulcerative Colitis.Gastroenterology clinics of North America, , 49 (4 ) ,769-789 More Information

Chiorean, Michael; Afzali, Anita; Cross, Raymond K; Macaulay, Dendy; Griffith, Jenny; Wang, Anthony; Garcia-Horton, Viviana (2020. ) Economic Outcomes of Inflammatory Bowel Disease Patients Switching to a Second Anti-Tumor Necrosis Factor or Vedolizumab.Crohn's & colitis 360, , 2 (2 ) ,otaa031 More Information

McMahon, Kevin R; Allen, Kenneth D; Afzali, Anita; Husain, Syed (2020. ) Predicting Post-operative Complications in Crohn's Disease: an Appraisal of Clinical Scoring Systems and the NSQIP Surgical Risk Calculator.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, , 24 (1 ) ,88-97 More Information

Menon, Tara; Afzali, Anita (2019. ) Immune-Mediated Colitis.Current treatment options in gastroenterology, , 17 (4 ) ,506-523 More Information

Alley, Kristen; Singla, Anand; Afzali, Anita (2019. ) Opioid Use Is Associated With Higher Health Care Costs and Emergency Encounters in Inflammatory Bowel Disease.Inflammatory bowel diseases, , 25 (12 ) ,1990-1995 More Information

Menon, Tara; Afzali, Anita (2019. ) Inflammatory Bowel Disease: A Practical Path to Transitioning From Pediatric to Adult Care.The American journal of gastroenterology, , 114 (9 ) ,1432-1440 More Information

Sobotka, Lindsay A; Crilley, Tessa; Levine, Edward; Afzali, Anita (2019. ) Acute Myelogenous Leukemia as a Rare Cause of Duodenal Ulcers.ACG case reports journal, , 6 (7 ) ,e00153 More Information

Afzali, Anita (2019. ) Inflammatory bowel disease during pregnancy: management of a disease flare or remission.Current opinion in gastroenterology, , 35 (4 ) ,281-287 More Information

Kruger, Andrew J; Hinton, Alice; Afzali, Anita (2019. ) To the Editors: Index Severity Score and Early Readmission Predicts Increased Mortality in Crohn's Disease Patients.Inflammatory bowel diseases, , 25 (7 ) ,e74-e76 More Information

Chen, Tong; Shi, Ni; Afzali, Anita (2019. ) Chemopreventive Effects of Strawberry and Black Raspberry on Colorectal Cancer in Inflammatory Bowel Disease.Nutrients, , 11 (6 ) , More Information

Afzali, Anita (2019. ) Update on Pregnancy in Patients With Inflammatory Bowel Disease. Gastroenterology & hepatology, , 15 (6 ) ,313-315

Kruger, Andrew J; Hinton, Alice; Afzali, Anita (2019. ) Index Severity Score and Early Readmission Predicts Increased Mortality in Ulcerative Colitis Patients.Inflammatory bowel diseases, , 25 (5 ) ,894-901 More Information

Afzali, Anita; Katz, Seymour (2018. ) Inflammatory Bowel Disease in the Baby to Baby Boomer: Pediatric and Elderly Onset of IBD.Current treatment options in gastroenterology, , 16 (3 ) ,289-305 More Information

Clowse, Megan E B; Scheuerle, Angela E; Chambers, Christina; Afzali, Anita; Kimball, Alexa B; Cush, John J; Cooney, Maureen; Shaughnessy, Laura; Vanderkelen, Mark; Förger, Frauke (2018. ) Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database.Arthritis & rheumatology (Hoboken, N.J.), , 70 (9 ) ,1399-1407 More Information

Afzali, Anita; Ciorba, Matthew A; Schwartz, David A; Sharaf, Mai; Fourment, Chris; Ritter, Timothy; Wolf, Douglas C; Shafran, Ira; Randall, Charles W; Kane, Sunanda V (2017. ) Challenges in Using Real-world Clinical Practice Records for Validation of Clinical Trial Data in Inflammatory Bowel Disease: Lessons Learned.Inflammatory bowel diseases, , 24 (1 ) ,2-4 More Information

Sandborn, William J; Wolf, Douglas C; Kosutic, Gordana; Parker, Gerry; Schreiber, Stefan; Lee, Scott D; Abraham, Bincy; Afzali, Anita; Arsenescu, Razvan I; Gutierrez, Alexandra; Spearman, Marshall; Coarse, Jason; Feagan, Brian G (2017. ) Effects of Transient and Persistent Anti-drug Antibodies to Certolizumab Pegol: Longitudinal Data from a 7-Year Study in Crohn's Disease.Inflammatory bowel diseases, , 23 (7 ) ,1047-1056 More Information

Afzali, Anita; Wahbeh, Ghassan (2017. ) Transition of pediatric to adult care in inflammatory bowel disease: Is it as easy as 1, 2, 3?.World journal of gastroenterology, , 23 (20 ) ,3624-3631 More Information

Afzali, Anita; Ogden, Kristine; Friedman, Michael L; Chao, Jingdong; Wang, Anthony (2017. ) Costs of providing infusion therapy for patients with inflammatory bowel disease in a hospital-based infusion center setting.Journal of medical economics, , 20 (4 ) ,409-422 More Information

Afzali, Anita; Sinanan, Mika N; Lee, Scott D (2017. ) Reply.Inflammatory bowel diseases, , 23 (1 ) ,E3 More Information

Afzali, Anita; Cross, Raymond K (2016. ) Racial and Ethnic Minorities with Inflammatory Bowel Disease in the United States: A Systematic Review of Disease Characteristics and Differences.Inflammatory bowel diseases, , 22 (8 ) ,2023-40 More Information

Afzali, Anita; Park, Christopher J; Zhu, Kehao; Hu, Jie Kate; Sharma, Prachi; Sinanan, Mika N; Lee, Scott D (2016. ) Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease.Inflammatory bowel diseases, , 22 (8 ) ,1887-95 More Information

Fausel, Rebecca; Afzali, Anita (2015. ) Biologics in the management of ulcerative colitis - comparative safety and efficacy of TNF-α antagonists.Therapeutics and clinical risk management, , 11 ,63-73 More Information

Kelly, Colleen R; Ihunnah, Chioma; Fischer, Monika; Khoruts, Alexander; Surawicz, Christina; Afzali, Anita; Aroniadis, Olga; Barto, Amy; Borody, Thomas; Giovanelli, Andrea; Gordon, Shelley; Gluck, Michael; Hohmann, Elizabeth L; Kao, Dina; Kao, John Y; McQuillen, Daniel P; Mellow, Mark; Rank, Kevin M; Rao, Krishna; Ray, Arnab; Schwartz, Margot A; Singh, Namita; Stollman, Neil; Suskind, David L; Vindigni, Stephen M; Youngster, Ilan; Brandt, Lawrence (2014. ) Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients.The American journal of gastroenterology, , 109 (7 ) ,1065-71 More Information

Afzali, Anita; Wheat, Chelle L; Hu, Jie Kate; Olerud, John E; Lee, Scott D (2014. ) The association of psoriasiform rash with anti-tumor necrosis factor (anti-TNF) therapy in inflammatory bowel disease: a single academic center case series.Journal of Crohn's & colitis, , 8 (6 ) ,480-8 More Information

Wolf, Douglas C; Abraham, Bincy P; Afzali, Anita; Allegretti, Paul D; Arai, Ronen (2012. ) Community Perspectives: Combining Serology, Genetics, and Inflammation Markers for the Diagnosis of IBD and Differentiation Between CD and UC. Gastroenterology & hepatology, , 8 (6 Suppl 2 ) ,1-16

Afzali, Anita; Berry, Kristin; Ioannou, George N (2012. ) Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States.Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, , 18 (1 ) ,29-37 More Information

Afzali, Anita; Weiss, Noel S; Boyko, Edward J; Ioannou, George N (2010. ) Association between serum uric acid level and chronic liver disease in the United States.Hepatology (Baltimore, Md.), , 52 (2 ) ,578-89 More Information

Afzali A.; Carlson C.; Lee S.; Wheat C. (06-01-2012. ) 31-Year-old male with frequent bleeding and portal vein thrombosis .Gastroenterology and Hepatology, , 8 (6 ) ,8-10

Afzali A.; Carlson C.; Lee S.; Wheat C. (06-01-2012. ) 31-Year-old male with frequent bleeding and portal vein thrombosis .Gastroenterology and Hepatology, , 8 (6 ) ,8-10

Fausel R.; Afzali A.; Afzali A. (01-01-2015. ) Biologics in the management of ulcerative colitis – comparative safety and efficacy of TNF-? antagon .Therapeutics and Clinical Risk Management, , 11 ,63-72

Fausel R.; Afzali A.; Afzali A. (01-01-2015. ) Biologics in the management of ulcerative colitis – comparative safety and efficacy of TNF-? antagon .Therapeutics and Clinical Risk Management, , 11 ,63-72

Afzali A.; Wheat C.L.; Lee S.D. (01-01-2014. ) Oral and parenteral corticosteroid therapy in ulcerative colitis.Medical Therapy of Ulcerative Colitis, , 111-120 More Information

Afzali A.; Wheat C.L.; Lee S.D. (01-01-2014. ) Oral and parenteral corticosteroid therapy in ulcerative colitis.Medical Therapy of Ulcerative Colitis, , 111-120 More Information

Tiderington E.; Afzali Md A. (05-01-2018. ) A practical approach to management of the patient with inflammatory bowel disease following tumor ne .Journal of Clinical Outcomes Management, , 25 (5 ) ,

Tiderington E.; Afzali Md A. (05-01-2018. ) A practical approach to management of the patient with inflammatory bowel disease following tumor ne .Journal of Clinical Outcomes Management, , 25 (5 ) ,

O’Malley R.B.; Hansen N.J.; Carnell J.; Afzali A.; Moshiri M. (08-01-2016. ) Update on MR Enterography: Potentials and Pitfalls.Current Radiology Reports, , 4 (8 ) , More Information

O’Malley R.B.; Hansen N.J.; Carnell J.; Afzali A.; Moshiri M. (08-01-2016. ) Update on MR Enterography: Potentials and Pitfalls.Current Radiology Reports, , 4 (8 ) , More Information

Afzali A. (01-01-2019. ) Update on pregnancy in patients with inflammatory bowel disease .Gastroenterology and Hepatology, , 15 (6 ) ,313-315

Afzali A. (01-01-2019. ) Update on pregnancy in patients with inflammatory bowel disease .Gastroenterology and Hepatology, , 15 (6 ) ,313-315

Chiorean M.; Afzali A.; Cross R.K.; Macaulay D.; Griffith J.; Wang A.; Garcia-Horton V. (04-01-2020. ) Economic outcomes of inflammatory bowel disease patients switching to a second anti-tumor necrosis f.Crohn's and Colitis 360, , 2 (2 ) , More Information

Hemperly A.; Dubinsky M.C.; Yarur A.; Afzali A.; Hanauer S.; Kugathasan S.; Long M.D.; Rabizadeh S.; Sockolow R.; Okada L.; Jain A.; Abreu M.T.; Vande Casteele N. (07-01-2021. ) Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic .Crohn's and Colitis 360, , 3 (3 ) ,1-8 More Information

Sands B.E.; Irving P.M.; Hoops T.; Izanec J.L.; Gao L.L.; Gasink C.; Greenspan A.; Allez M.; Danese S.; Hanauer S.B.; Jairath V.; Kuehbacher T.; Lewis J.D.; Loftus E.V.; Mihaly E.; Mihaly E.; Panaccione R.; Scherl E.; Shchukina O.B.; Sandborn W.J.; Afzali A.; Aitova L.; Aldeguer i Mante X.; Altorjay I.; Argüelles Arias F.; Armuzzi A.; Augustyn M.; Bafutto M.; Barrio J.; Begun J.; Behrend C.; Bezemer G.; Bonnaud G.; Brankovic M.; Byung I.J.; Calvet Calvo X.; Chachu K.; Chebli J.M.F.; Cheon J.H.; Cichoz-Lach H.; Clark L.; Cummings F.; Dalal K.; De Boer N.; De Lourdes Ferrari M.; Désilets E.; Dugalic P.; Duvall G.; Fedorishina O.; Filip R.; Flores C.; Fogel R.; Fon J.; Frankel M.; Friedenberg K.; Fries W.; Galina V.; Gietka P.; Goel R.; Hasselblatt P.; Herfarth H.; Herszényi L.; Hindryckx P.; Hoentjen F.; Horjus Talabur Horje C.; Iduru S.; Isfort R.; Jones M.; Kalimullina D.; Katz J.; Kaur M.; Khurana S.K.; Kim J.S.; Kim Y.; Kleczkowski D.; Knezevic S.; Knoll A.; Korman L.Y.; Kotzev I.; Kulyapin A.; Lee K.M.; Leemreis D.; Leszczyszyn J.; Limdi J.; Lissauer J.; Loftus E.; Malecka-Panas E.; Marshall J.; Milan L.; Monteleone G.; Nagorni A.; Owczarek D.; Palekar N.; Park Y.S.; Park S.H.; Parra R.; Patai Á.; Patel K.; Patel B.; Pershko A. (06-11-2022. ) Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with .The Lancet, , 399 (10342 ) ,2200-2211 More Information

Pusateri A.; Anaizi A.; Nemer L.; Hinton A.; Lara L.; Afzali A. (04-01-2022. ) Impact of Cannabis Use on Inpatient Inflammatory Bowel Disease Outcomes in 2 States Legalizing Recre.Crohn's and Colitis 360, , 4 (2 ) , More Information

Axelrad J.; Long M.; Horst S.; Afzali A.; Sapir T.; Fajardo K.; De Felice K.; Sandler R.; Cross R. (12-01-2022. ) A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With .JMIR Research Protocols, , 11 (12 ) , More Information

Danese S.; Panaccione R.; Feagan B.G.; Afzali A.; Rubin D.T.; Sands B.E.; Reinisch W.; Panés J.; Sahoo A.; Terry N.A.; Chan D.; Han C.; Frustaci M.E.; Yang Z.; Sandborn W.J.; Hisamatsu T.; Andrews J.M.; D'Haens G.R.; Oliinyk O.; Bilianskyi L.; Gniady-Jastrzebska J.; Petryka R.; Arlukowicz T.; Gietka P.; Zmudzinski M.; Mumtaz S.; Wolf D.; Wojcik K.; Duvall G.; Augustyn M.; Filip R.; Tarabar D.; Tkachev A.; Seidler U.; Zittan E.; Pokrotnieks J.; Shchukina O.; Machavariani A.; Loy L.; Abu-farsakh N.; Marina P.; Sreckovic S.; Laclav M.; Wei S.C.; Suiter D.; Borsuk A.; Hebuterne X.; Buning C.; Lahat-Zok A.; Danilkiewicz W.; Frysna B.; Jovicic I.; Datsenko O.; Guram M.; Jain A.; Rashid Z.; Heeren S.; Shulga N.; Timkin I.; Gornjakovic S.; Lukas M.; Altwegg R.; Desjeux A.; Reimund J.M.; Giorgadze M.; Jochum C.; Ito H.; Nakai K.; Takagi T.; Zaha O.; Choi C.; Kim T.; Lee J.; Stundiene I.; Hilmi I.N.; Hj Md Said R.; Leszczyszyn J.; Abdulganieva D.; Fominykh Y.; Maksyashina S.; Balaz J.; Van Domselaar M.; Kav T.; Dennis P.; Henry P.; Holmes R.; Johnson C.; McBride M.; Sarles H.; Moore G.; Yakubtsevich R.; Muls V.; Trbojevic S.; Afif W.; Bernstein C.; Klarin I.; Serclova Z.; Volfova M.; Desreumaux P.; Gilletta de Saint Joseph C. (01-01-2023. ) Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results.The Lancet Gastroenterology and Hepatology, , More Information

Academic - MSB
231 Albert Sabin Way
Cincinnati  Ohio, 45267